HURA

TuHURA Biosciences, Inc.

Sağlık

NON-COMPLIANT — One or more ratios exceed the threshold; the company is not compliant with halal investment criteria.

$1.45

Price (1 Year)

$2.92 $0.54

Participation Finance Screening Ratios

Non-compliant debt / Total market cap %7.2 / %30
Non-compliant assets / Total market cap %0 / %30
Non-compliant revenue / Total income %100 / %5

Ratios are taken from an AAOIFI-based screening file; this does not constitute a religious ruling.

About the Company

TuHURA Biosciences, Inc., a clinical stage immuno-oncology company, that develops novel technologies for the treatment of cancer immunotherapies. The company's lead product candidate includes IFx2.0, an innate immune agonist designed to overcome primary resistance to checkpoint inhibitors.

Website

Analysis (Turkish): HURA Hissesi Caiz mi, Helal mi? TuHURA Biosciences, Inc. Katılım Analizi